Mechanism-based Reversibility Evaluation and Stratified Endophenotyping of Treatment-response in ME/CFS
Dauer: 36 Monate, Fördersumme: € 999.930
Beyond lipid lowering - defining residual risk of cardiovascular events
Dauer: 61 Monate, Fördersumme: € 736.660